Vertex: Q4 Earnings Snapshot

robot
Abstract generation in progress

Vertex Pharmaceuticals Inc. reported fourth-quarter net income of $1.19 billion, or $4.65 per share, with adjusted earnings of $5.03 per share. This fell short of Wall Street’s expectation of $5.07 per share. Despite missing profit estimates, the company’s revenue of $3.19 billion surpassed forecasts.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
0/400
No comments
  • Pin

Trade Crypto Anywhere Anytime
qrCode
Scan to download Gate App
Community
English
  • 简体中文
  • English
  • Tiếng Việt
  • 繁體中文
  • Español
  • Русский язык
  • Français
  • Deutsch
  • Português (Portugal)
  • ภาษาไทย
  • Indonesia
  • 日本語
  • بالعربية
  • Українська
  • Português (Brasil)